Showing results (41-50 of 47) with videos related to
Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
Ejhaem|July 18, 2022
Pembrolizumab for the treatment of progressive multifocal leukoencephalopathy following anti-CD19 CAR-T therapy: a case reportStrachan Mackenzie, Manar Shafat, Harriet Roddy, et al.Scientific Reports|June 10, 2020
Noninvasive diffusion magnetic resonance imaging of brain tumour cell size for the early detection of therapeutic responseThomas A Roberts, Harpreet Hyare, Giulia Agliardi, et al.Practical Neurology|January 6, 2026
CAR-T cells in the treatment of neurological autoimmune diseasesFrederick W Vonberg, Benjamin E Schroeder, Amy Edwards, et al.Nature Communications|October 22, 2021
Comparative epigenetic analysis of tumour initiating cells and syngeneic EPSC-derived neural stem cells in glioblastomaClaire Vinel, Gabriel Rosser, Loredana Guglielmi, et al.Nature Communications|May 7, 2025
Genomic landscape of diffuse glioma revealed by whole genome sequencingBen Kinnersley, Josephine Jung, Alex J Cornish, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 2, 2026
Temozolomide Versus Radiotherapy as First-Line Therapy for Low-Grade Glioma: Mature Results of a Randomized Phase III Trial (EORTC 22033-26033/NCIC-CTG/TROG/MRC-CTU)Brigitta G Baumert, Monika E Hegi, Martin J van den Bent, et al.The Lancet. Oncology|October 1, 2016
Temozolomide chemotherapy versus radiotherapy in high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup studyBrigitta G Baumert, Monika E Hegi, Martin J van den Bent, et al.Pageof 5